Rigel Pharmaceuticals Inc (RIGL): Depreciation & Amortization
$2.42M
Year ended 2025-12-31
$2.65M
Trailing 12 months to 2026-06-30
+34.3%
3-year compound annual growth
+27.9%
5-year compound annual growth
+5.3%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.42M | +8.4% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $2.23M | +80.0% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $1.24M | +24.0% | 2026-03-03, From 2023-01-01 |
| 2022-12-31 | $998.0K | -14.1% | 2025-03-04, From 2022-01-01 |
| 2021-12-31 | $1.16M | +64.6% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $706.0K | +3.4% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $683.0K | +15.0% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $594.0K | +27.7% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $465.0K | -50.6% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $941.0K | -34.6% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $1.44M | -39.0% | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | $2.36M | -9.0% | 2017-03-07, From 2014-01-01 |
| 2013-12-31 | $2.59M | +6.5% | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | $2.43M | +24.5% | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | $1.96M | +48.4% | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | $1.32M | -6.1% | 2013-03-05, From 2010-01-01 |
| 2009-12-31 | $1.40M | n/a | 2012-03-06, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Rigel Pharmaceuticals Inc (RIGL) | 2025-12-31 | $2.42M | +8.4% |
| Rapport Therapeutics, Inc. (RAPP) | 2025-12-31 | $1.02M | +21.2% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $3.06M | +48.3% |
| Olema Pharmaceuticals, Inc. (OLMA) | 2025-12-31 | $490.0K | +24.7% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $500.0K | -28.6% |
| Enliven Therapeutics, Inc. (ELVN) | 2025-12-31 | $300.0K | 0.0% |
| Standard Biotools Inc. (LAB) | 2025-12-31 | $9.26M | -26.0% |
| Geron Corp (GERN) | 2025-12-31 | $474.0K | -13.2% |
| Biohaven Ltd. (BHVN) | 2025-12-31 | $9.92M | +26.3% |
Compare RIGL, RAPP, ARDX, OLMA side by side · Screen every company in Pharmaceutical Preparations ↗